Transcription
Cherry Wyant Jackson, PharmD, FASHP, FCCP, BCPPBusiness Address:Alabama, BirminghamDepartment of Psychiatry and Behavioral Neurobiology933 19th Street South, CH-19, Suite 308XPhone: 205-975-8192Fax: 205-975-3692Email: cwj0002@auburn.eduLicensure:Home Address: University of7075 Lake Run DriveVestavia Hills, Alabama 35242Phone: 205-789-6039Fax: 205-849-6806DOB: May 28, 1959Email: cjackson25@gmail.comAL # 15904 (active), SC #6609, (active), GA #022492Education and TrainingPsychiatric Pharmacy Specialty Residency (ASHP Accredited)Medical University of South Carolina College of PharmacyCharleston, South CarolinaJuly 1989-June 1990Doctor of PharmacyMedical University of South Carolina College of PharmacyCharleston, South CarolinaSeptember 1987-May 1989Bachelor of Science in PharmacyMedical University of South Carolina College of PharmacyCharleston, South CarolinaSeptember 1983-May 1986Bachelor of Science in Biology (major)Chemistry/Business Administration (minor)Winthrop CollegeRock Hill, South CarolinaSeptember 1977-May 1981AppointmentsInterim Department HeadDepartment of Pharmacy PracticeAuburn University Harrison School of PharmacyAuburn, AlabamaTenureDepartment of Pharmacy PracticeAuburn University Harrison School of PharmacyAuburn, AlabamaJuly 2018-November 2018October 2011- presentClinical ProfessorDepartment of Psychiatry and Behavioral NeurobiologyUniversity of Alabama, BirminghamBirmingham, AlabamaOctober 2008-presentProfessorDepartment of Pharmacy PracticeAuburn University, Harrison School of PharmacyAuburn, AlabamaJanuary 2007-presentUpdated January 2019
Curriculum vitaeCherry Wyant JacksonClinical Professor (adjunct)Department of Clinical and Administrative PharmacyUniversity of GeorgiaAthens, GeorgiaClinical PharmacistDepartment of PharmacyMemorial Heath University Medical CenterSavannah, GeorgiaOctober 2005-January 2007July 2005-January 2007Professor and Assistant DeanAcademics, Admissions, Student AffairsSouth University School of PharmacySavannah, GeorgiaJuly 2002-June 2005Associate Professor with TenureDepartment of Pharmacy PracticeMedical University of South CarolinaCharleston, South CarolinaJuly 1998-July 2002Associate ProfessorDepartment of Pharmacy ServicesMedical University of South CarolinaCharleston, South CarolinaJuly 1996-July 1998Assistant ProfessorDepartment of Psychiatry and Behavioral SciencesCollege of MedicineMedical University of South CarolinaCharleston, South CarolinaJuly 1994-July 2002Assistant Professor of PharmacyHospital Pharmacy Practice and AdministrationMedical University of South CarolinaCollege of PharmacyCharleston, South CarolinaJuly 1991-July 1996Psychiatric Pharmacy Residency DirectorMedical University College of PharmacyMedical University of South CarolinaCharleston, South CarolinaAugust 1990-July 2002Registrar (HOPE Scholarships)South University School of PharmacySavannah, GeorgiaJuly 2002-July 2005Designated School Official (DSO) SEVISSouth University School of PharmacySavannah, GeorgiaJuly 2002- July 20052
Curriculum vitaeCherry Wyant JacksonInternational Student AdvisorSouth University School of PharmacySavannah, GeorgiaJuly 2002-July 2005Interim Clinical CoordinatorInstitute of PsychiatryMedical University of South CarolinaCharleston, South CarolinaMay 2001-July 2002Director/Coordinator of Pharmacy ServicesInstitute of PsychiatryMedical University of South CarolinaCharleston, South CarolinaAugust 1990-July 1997Clinical CoordinatorInstitute of PsychiatryMedical University of South CarolinaCharleston, South CarolinaAugust 1990-July 1999CertificationsMental Health First Aid Teaching CertificationSuicide Prevention (QPR) Teaching CertificationAlabama Pharmacy Preceptor CertificationJuly 2016-presentSeptember 2015-presentFebruary 2007-December 2012APhA Pharmacy-Based Immunization Delivery/Training CertificationJuly 2004-presentACPE Continuing Education ProviderJuly 2002-presentNational Provider CertificationMedicaid Provider Certification, State of South CarolinaBoard Certification in Psychiatric Pharmacotherapy (#496103)Basic Life Support CertificationHonors and AwardsFellow of the American College of Clinical PharmacyAcademic Research Program FellowWho’s Who in Medicine and Health CareFellow of the American Society of Health-System PharmacistsVisiting Expert, Ministry of SingaporeWho’s Who in Medicine and ScienceTenured, Auburn UniversityTenured, Medical University of South CarolinaKey 100, Medical University of South CarolinaJanuary 2007-presentJanuary 1997-presentDecember 1996-presentRenewed 2004(exam), 2011, 2018April 199819963
Curriculum vitaeCherry Wyant JacksonTeaching AwardsPreceptor of Excellence, Auburn UniversityRoche Preceptor of the Year, Class of 2001Professor of the Year, Entry Level PharmD, Class of 2001Professor of the Year, Post Baccalaureate PharmD Class of 2000Roche Preceptor of the Year, PharmD, Class of 2000Professor of the Year, Medical Residents, Department of PsychiatryHealth Science Foundation, Teaching Excellence Award NomineeResearch AwardsCollege of Pharmacy Research Productivity AwardDepartment of Pharmacy Practice Research Productivity AwardService/Outreach AwardsAlabama Society of Health-System Pharmacists Health-System Pharmacist of the YearAlabama Society of Heath-System Pharmacists Leadership AwardAlabama Society of Health-System Pharmacists Leadership AwardAlabama Society of Health-System Pharmacists Service AwardAlabama Society of Health-System Pharmacists Service AwardAlabama Society of Health-System Pharmacists Leadership AwardAlabama Society of Health-System Pharmacists Leadership AwardCollege of Psychiatric and Neurologic Pharmacists Service AwardAmerican Society of Health-System Pharmacists Service AwardPhi Lambda Sigma Leadership SocietyPatient Satisfaction AwardApplause AwardClinical Specialist of the YearUpjohn Achievement AwardPfizer Pharmaceutical Community Pharmacy Leadership AwardOmicron Delta Kappa Leadership Auburn University (teaching or facilitating only. Only coordinate Psychiatry Elective)Advanced Pharmacy Practice Experience (APPE’s)Academic Elective (PYPP 5670/PYDI 9760/9660)2018-presentPrimary Care (PYPP 5640/5650/5660; PYDI 9640/9650)2007-presentPrimary Care Elective2007-presentIntroductory Pharmacy Practice Experience (IPPE’s)Pharmacy Practice Experience I, III, V (PYDI 5190/5390/5590)2007-presentPharmacy Practice Experience II,IV,VI (PYDI 5090/5290/5490)2007-presentIntegrated Learning Experiences (ILE)Integrated Learning Experience ILE-2 (PYDD 9210)2017-presentDepressionIntegrated Learning Experience ILE-5 (PYDD 9240)Schizophrenia2018-present4
Curriculum vitaeCherry Wyant JacksonBipolar Affective DisorderGeneralized Anxiety DisorderSleepIntegrated Pharmacotherapy I-IV (PYDI 5470/9470; 5480/9480; 5570/9570; chizophrenia2011-2018ElectivesPsychiatric Pharmacotherapy (Coordinator) (PYDI 9796)2008-presentEvidence Based Pharmacotherapy2009, 2017Women’s Health (PYPP 5770)2008-2014Contemporary Aspects of Pharmacy Practice (CAPP)Contemporary Aspects of Pharmacy Practice I (PYDI 5020)2007-2017Contemporary Aspects of Pharmacy Practice II (PYDI 5120)2007Contemporary Aspects of Pharmacy Practice VI (PYDI 5520)2007-2011Contemporary Aspects of Pharmacy Practice VII (PYDI 5680)2007-2011Foundations of Pharmacy (PYDI 5080)Orientation2010-20162017-presentSeminar (PYDI 5680/PYPP 5690)2007-2017Manuscript/Poster Advisor (PYDI 5680)2007-2010Pharmacotherapy VI (PYDI 5510)Psychiatry2007-2008Non-traditional PharmacotherapyPsychiatry2007-2009University of Alabama, Birmingham School of Medicine (Course Coordinator)Advanced Psychopharmacology (Psychiatry Residents, PGY 3)2013-presentPsychopharmacology (Psychiatry Residents, PGY-1)2008-presentPsychopharmacology (Nurse Practitioner Residents)2008-presentUniversity of GeorgiaAdvanced Practice Experience-Acute Care2005-2007Advanced Practice Experience-Primary Care2005-2007South University School of Pharmacy (Coordinator of both classes)5
Curriculum vitaeCherry Wyant JacksonIntegrated Sequence IIIPsychiatry and NeurologyIntroduction to Professional Practice2004-20052003-2005Medical University of South Carolina (MUSC) (coordinator of all courses taught)SeminarPharm.D. Seminar Series (Entry Level Pharm.D) Coordinator2000-2002Grand Rounds Coordinator1999-2002Grand Rounds Advisor1991-1998New Drug Seminar Series1991-1994Doctoral Research ProjectsSpecial Projects1991-20021993-2002Advanced Practice Pharmacy Experiences (APPEs)Acute Care Psychiatry1991-2002Neurology Module Coordinator1995-2002Psychiatry Module Coordinator1993-2002Clinical Pharmacy I1990-2002Clinical Pharmacy II1990-2002Clinical Pharmacokinetics1990-1993Residency TrackResearch Methods Course1995-2002Advanced Therapeutics1995-2002Advanced Clinical Pharmacy1990-2002Medical University of South Carolina College of MedicineIntroduction to Clinical Medicine (ICM-I) (taught)1995-2002Introduction to Clinical Medicine (ICM-II) (taught)1995-2002Psychopharmacology (PGY1-4 Psychiatry Residents) Coordinator1993-2002Psychopharmacology (Psychology Residents)1991-2002Medical University of South Carolina College of Health SciencesNeurology and Psychiatry Pharmacology (Physician Assistants)2004-2005Neurology and Psychiatry Pharmacology (Physician Assistants)1995-20026
Curriculum vitaeCherry Wyant JacksonMedical University of South Carolina College of NursingNursing PharmacologyPsychopharmacology (Nurse Practitioner Residents)19902013-2002Trident Technical CollegePharmacy Technician llner CK, Jackson CW, DeVane CL. “Composition and Methods for Treating Performance Anxiety.” U.S.Patent # 5,525,347. June 1996.Total Number of Publications: 47Total Number of Citations: 941Citations 2018: 23h-index: 18Peer Reviewed Publications (*denotes student/resident)Andrus MR, McDonough SLK, Kelley KW, Stamm PL ,McCoy EK, Lisenby KM, Whitley HP, Slater N, Carroll DG,Hester EK, Helmer AM, Jackson CW, Byrd DC. Development and validation of a rubric to evaluate diabetesSOAP note writing in APPE. Am J Pharm Educ, Nov 2018; 82(9): 6725. Doi 10.5688/ajpe6725.Lisenby KM, Andrus MR, Jackson CW, Stevenson TL, Fan S, Gaillard P, Carroll DG. Ambulatory carepreceptors’ perceptions on SOAP note writing in advanced pharmacy practice experiences (APPEs). CurrPharm Teach Learn. 2018 Dec; 0(12):1574-1578. Doi: 10.1016/j.cptl.2018.09.002. Epub 2018 Sep 13.Noel JL, Jackson CW. American Society of Health-System Pharmacists Therapeutic Position Statement on theUse of Second-Generation Antipsychotics in the Treatment of Adults with Psychotic Disorders. AmericanJournal of Health-System Pharmacists. (Invited) (In press).Jackson CW. Movies and mental illness. A psychiatric elective for third year pharmacy students. MentalHealth Clinician. (Invited) 2013; 2(10):90-96.Farguson RE, Gamble K, Avis KT, Besing RC, Jackson CW, Cates ME, May R. Ramelteon for insomnia related toattention-deficit/hyperactivity disorder (ADHD). Psychopharmacology Bulletin 2011; 44(2) 1-22.Jackson CW, Lorenz RA, Cates ME. Pharmacotherapy of eating disorders. Nutrition in Clinical Practice.(Invited) 2010; 25:143-59.Lorenz RA, Jackson CW, Saitz MA. Adjunctive use of atypical antipsychotics for treatment-resistantgeneralized anxiety disorders. Pharmacotherapy. 2010; 9:942-51.Cates ME, Jackson CW, Feldman JM, Stimmel AE, Woolley TW. Metabolic consequences of using low-dosequetiapine for insomnia in psychiatric patients. Community Mental Health Journal. 2009; 45:251-4.Coveyou JS, Jackson CW. Hyponatremia associated with escitalopram. New England Journal of Medicine.2007; 356:94-96.7
Curriculum vitaeCherry Wyant JacksonJackson CW. The role of second generation antipsychotics in the treatment of psychotic disorders. AmericanJournal of Health-System Pharmacists. (Invited) 2007; 64:815.Jackson CW, Sheehan AH, Reddan JG. An evidence based review of the “black box” warning for droperidoluse. American Journal of Health System Pharmacy. (Invited) 2007; 64 (11): 1174-86.Jackson CW, Jackson KH. Co-morbid depression in adult oncology. Journal of Pharmacy Practice. (Invited)2007; 20:360-7Gropper D*, Jackson CW. Pancreatitis associated with quetiapine use. Journal of ClinicalPsychopharmacology. 2004; 24: 343-5.Markowitz JS, McLeod-Bryant S, Jackson CW. Cost-savings with intramuscular antipsychotics. Journal ofClinical Psychiatry, 2001; 62:295.Markowitz JS, Carson WH, Jackson CW. Possible dihydroepiandrosterone-induced mania. BiologicalPsychiatry. 1999; 45:241-2.Chappell K*, Markowitz J, Jackson C. Is valproate pharmacotherapy associated with polycystic ovaries?Annals of Pharmacotherapy. 1999; 45:241-2.Snead T*, Jackson CW. St. John’s wort: A review of an all-natural antidepressant. Journal of PharmacyPractice. (Invited) 1999; 12:210-16.Algozzine TW*, Pitner JK, Mintzer JE. Jackson CW. The use of very low dose lorazepam for agitation in elderlypersons with dementia. Consultant Pharmacist. 1999; 14; 868-72.Jackson CW. Epilepsy: 199 answers (a doctor responds to his patients questions.) Annals ofPharmacotherapy. (Invited) 1998; 32:1255-56.Jackson CW. Antidepressants in the treatment of chronic pain. (Invited) Journal of Pharmacy Practice.(Invited) 1998; 6:388-93.Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette’s disorder inchidren. Results of an open-label trial of pergolide. Movement Disorders . 1997; 12: 402-7.Sallee FR, Nesbitt L, Jackson C. Relative efficacy of haloperidol and pimozide in children and adolescents withTourette’s disorder. American Journal of Psychiatry, 1997; 154:1057-62.Pitner JK, Mintzer JE, Pennypacker LC, Jackson CW. Use of clozapine in elderly psychotic patients. A report ofefficacy and adverse effects in four consecutive cases. Dementia 1997; 2:18-19.Markowitz JS, Grinberg R, Jackson C. Marked liver elevations with clozapine. Journal of ClinicalPsychopharmacology. 1997; 17:70-71.Tankersley MA, Jackson CW, Ford FR*. Common drug interactions with psychotropic agents. Presented asan educational publications by diversified health services/service master. www.syndhs.com 1997.Markowitz JS, Jackson CW. Use of clozapine with non-responsive patients. Psychiatric Services. 1996;47:1392.8
Curriculum vitaeCherry Wyant JacksonAlgozzine TW*, Pitner JK, Mintzer JE, Jackson CW. Evaluation of the effectiveness of lorazepam for thetreatment of agitation in the demented elderly. Pharmacotherapy. 1996; 16:55.Jackson CW, Pitner JK, Mintzer J. Zolpidem for the treatment of agitation in elderly demented patietns.Journal of Clinical Psychiatry. 1996; 57:372-3.Jackson CW. Pharmacologic treatment of bipolar disorder throughout the life cycle. Journal of PharmacyPractice. (Invited) 1996; 9: 1-10.Markowitz JS, Jackson CW. Savings on nutritional supplements administered to patients with chronicalcoholism. American Journal of Health-System Pharmacists. 1996; 53:1336.Jackson CW, Bachman DS. Narcolepsy related psychosis misinterpreted as schizophrenia. Neuropsychiatry,Neuropsychology, and Behavioral Neurology. 1996; 9:57-8.Jackson CW. Obsessive compulsive disorder in elderly patients. Drugs and Aging. (Invited) 1995; 7:438-48.Jackson CW, Markowitz JS, Brewerton TD. Delirium associated with clozapine and benzodiazepinecombinations. Annals of Clinical Psychiatry. 1995; 7:139-41.Jackson CW, Carson WH, Markowitz JS, Mintzer J. SIADH associated with fluoxetine and sertraline. AmericanJournal of Psychiatry. 1995; 152:809-10.Pitner JK, Mintzer J, Pennypacker L, Jackson CW. The use of clozapine in four elderly demented patients: areport of the efficacy and adverse events in four consecutive cases. Journal of Clinical Psychiatry. 1995; 56:180-85.Jackson CW, Cunningham K*, Compatibility of haloperidol lactate with benztropine mesylate. AmericanJournal of Hospital Pharmacy. 1994; 51:2963.Brewerton TD, Jackson CW. Prophylaxis of carbamazepine-induced hyponatremia with demeclocycline.Journal of Clinical Psychiatry. 1994; 55:249-51.Kellner CH, Pritchett JT, Jackson CW. Bupropion co-administration with electroconvulsive therapy: twocase reports. Journal of Clinical Psychopharmacology. 1994; 14:215-5.Jackson CW, Morton WA, Lydiard RB. Pharmacologic management of obsessive-compulsive disorder.Southern Medical Journal. 1994; 87:310-21.Morton WA, Jackson CW, Santos AB, Gullstrand E. Clonazepam for psychiatric disorders A look at its use inan inpatient psychiatric facility. Hospital Formulary. 1992; 27:407-10.Jackson CW, Head LA, Kellner CH. Catatonia associated with bupropion treatment. Journal of ClinicalPsychiatry. 1992; 53:210.Lydiard RB, Jackson CW. Tricyclic-induced activation/jitteriness. Journal of Clinical Psychopharmacology.1991; 11:394-5.9
Curriculum vitaeCherry Wyant JacksonJackson CW, Lydiard RB. Two cases of activation/jitteriness associated with tricyclic antidepressants. Journalof Clinical Psychopharmacology 1990; 10:439-40.Jackson CW, Caldwell RD, Arford PD. A cost comparison of intravenous cimetidine delivery systems. HospitalPharmacy. 1990; 25:1085-9.Articles in Non-Refereed Journals (*denotes student/resident)Jackson CW. Update on collaborative drug therapy management. In-Pharmative Quarterly. (Invited) January2018Jackson CW. Collaborative drug therapy management. In-Pharmative Quarterly. (Invited) January 2016.Jackson CW. Use of antipsychotics in children. West Virginia Behavioral Health Newsletter. (Invited) April2015Jackson CW, Taylor K. The role of the pharmacist in oncology care. Technique. (Invited) 2007; 4.Jackson CW. Taylor K. The role of the pharmacist in cancer care. HOPE. (Invited) 2007; 3-4.Hussey T*, Jackson C, Markowitz J. Selective serotonin reuptake inhibitors: the potential for hemostasis.College of Psychiatric and Neurologic Pharmacists Newsletter . Fall edition 1999.Jackson CW. Update in the treatment of depression. Glaxo-Wellcome. Trends in Pharmacy. (Invited) 1998.Wyant C, Caldwell RD, Arford PD. A cost comparison of intravenous cimetidine delivery systems. Search:Improved Nursing Care through Research. (Invited) 1990; 2-4.Wyant C. Fluoxetine-a new bicyclic antidepressant. Pharmacy Review. 1988; 10:3-4.Book Chapters and Enduring (Licensed) Products (all invited)McGuire M, Jackson CW. Cates M. Depression. In: Chisolm-Burns MA, Schwinghammer TL, Wells BG, MalonePM, Kolesar JM, Dipiro J . (Eds) Pharmacotherapy: Principles and Practice, Fifth Editions. McGraw HillCompany. January 2019.Jackson CW. Eating Disorders in Children and Adolescents. Pediatric Pharmacotherapy. American College ofClinical Pharmacy (accepted).Slater N, Jackson CW. Depression. In: Katz MD, Matthias KR, Chisolm MA. (Eds.) Pharmacotherapy: Principlesand Practice Casebook, Fourth Edition. McGraw Hill Company. 2016.Jackson CW. Cates ME. Depression. In: Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM,Kolesar JM, Dipiro J. (Eds.) Pharmacotherapy Principles and Practice, Fourth Edition. McGraw Hill Company,2016.Cates ME, Jackson CW. Post-traumatic Stress Disorder. In: Dong BJ, Elliott DP (Eds.) Ambulatory Care SelfAssessment Program (ACSAP): Neurologic and Psychiatric Care II. 2015.10
Curriculum vitaeCherry Wyant JacksonJackson CW. Anxiety and Depression in Elderly Patients. American Society of Consultant Pharmacists, BoardCertification in Geriatric Pharmacy Enduring Product. 2015Davis LL, VanDeventer LJ, Jackson CW. Chapter 26: Pharmacologic Therapy for Trauma Related PsychologicalDisorders. In: Schynder U, Cloitre M. (Eds.) Evidenced based treatment for trauma related disorder: A PracticalGuide for Clinicians. Springer, Zurich, Switzerland, 2015.Jackson CW. Depression. In: Katz MD, Matthias KR, Chisholm MA, (Eds.) Pharmacotherapy: Principles andPractice Casebook, Third Edition. McGraw Hill Company. 2014: 161-4.Jackson CW. Eating Disorders in Children and Adolescents. Pediatric Pharmacotherapy. American College ofClinical Pharmacy. 2013; 449-464.Jackson CW, Cates ME. Depression. In: Chisholm-Burns MA, Schwinghammer TL, Wells BC, Malone PM,Kolesar JM, Dipiro J. (eds.) Pharmacotherapy: Principles and Practice, Third Edition. McGraw Hill Company.2013; 677-93.Jackson CW, Lorenz RA, Cates ME. Depression. In: Katz MD, Matthias KR, Chisholm MA. (Eds)Pharmacotherapy: Principles and Practice Casebook, Second Edition. McGraw Hill Company. 2011; 153-156.Jackson CW, Cates ME, Feldman JM. Depression. In: Chisholm-Burns MA, Schwinghammer TL, Wells BG,Malone PM, Kolesar JM, Dipiro J. (Eds) Pharmacotherapy: Principles and Practice, Second Edition. McGrawHill Company. 2010; 653-68.Jackson CW. Depression. College of Psychiatric and Neurologic Pharmacists. Board of PharmaceuticalSpecialties Review Course. 2009Jackson CW. Treatment of Schizophrenia and Movement Disorders. College of Psychiatric and NeurologicReview Course. Board of Pharmaceutical Specialties Review Course. 2009Jackson CW. Personality and Eating Disorders. College of Psychiatric and Neurologic Pharmacist. Board ofPharmaceutical Specialties Review Course. 2009Jackson CW. Treatment of Depressive Disorder: Home Study and Literature Analysis. College of Psychiatricand Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2009Jackson CW. Treatment of Personality and Eating Disorders. Home Study and Literature Analysis. College ofPsychiatric and Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2009Jackson CW. Treatment of Schizophrenia and Movement Disorders. Home Study and Literature Analysis.College of Psychiatric and Neurologic Pharmacists Review Course. 2009Jackson CW. Depression. College of Psychiatric and Neurologic Pharmacists. Board of PharmaceuticalSpecialties Review Course. 2008Jackson CW. Treatment of Schizophrenia and Movement Disorders. College of Psychiatric and NeurologicReview Course. Board of Pharmaceutical Specialties Review Course. 2008Jackson CW. Personality and Eating Disorders. College of Psychiatric and Neurologic Pharmacist. Board ofPharmaceutical Specialties Review Course. 200811
Curriculum vitaeCherry Wyant JacksonJackson CW. Treatment of Depressive Disorder: Home Study and Literature Analysis. College of Psychiatricand Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2008Jackson CW. Treatment of Personality and Eating Disorders. Home Study and Literature Analysis. College ofPsychiatric and Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2008Jackson CW. Treatment of Schizophrenia and Movement Disorders. Home Study and Literature Analysis.College of Psychiatric and Neurologic Pharmacists Review Course. 2008Jackson CW. Depression. College of Psychiatric and Neurologic Pharmacists. Board of PharmaceuticalSpecialties Review Course. 2007Jackson CW. Treatment of Schizophrenia and Movement Disorders. College of Psychiatric and NeurologicReview Course. Board of Pharmaceutical Specialties Review Course. 2007Jackson CW. Personality and Eating Disorders. College of Psychiatric and Neurologic Pharmacist. Board ofPharmaceutical Specialties Review Course. 2007Jackson CW. Treatment of Depressive Disorder: Home Study and Literature Analysis. College of Psychiatricand Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2007Jackson CW. Treatment of Personality and Eating Disorders. Home Study and Literature Analysis. College ofPsychiatric and Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2007Jackson CW. Treatment of Schizophrenia and Movement Disorders. Home Study and Literature Analysis.College of Psychiatric and Neurologic Pharmacists Review Course. 2007Jackson CW. Depression. College of Psychiatric and Neurologic Pharmacists. Board of PharmaceuticalSpecialties Review Course. 2006Jackson CW. Treatment of Schizophrenia and Movement Disorders. College of Psychiatric and NeurologicReview Course. Board of Pharmaceutical Specialties Review Course. 2006Jackson CW. Personality and Eating Disorders. College of Psychiatric and Neurologic Pharmacist. Board ofPharmaceutical Specialties Review Course. 2006Jackson CW. Treatment of Depressive Disorder: Home Study and Literature Analysis. College of Psychiatricand Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2006Jackson CW. Treatment of Personality and Eating Disorders. Home Study and Literature Analysis. College ofPsychiatric and Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2006Jackson CW. Treatment of Schizophrenia and Movement Disorders. Home Study and Literature Analysis.College of Psychiatric and Neurologic Pharmacists Review Course. 2006Jackson CW. Depression. College of Psychiatric and Neurologic Pharmacists. Board of PharmaceuticalSpecialties Review Course. 200512
Curriculum vitaeCherry Wyant JacksonJackson CW. Treatment of Schizophrenia and Movement Disorders. College of Psychiatric and NeurologicReview Course. Board of Pharmaceutical Specialties Review Course. 2005Jackson CW. Personality and Eating Disorders. College of Psychiatric and Neurologic Pharmacist. Board ofPharmaceutical Specialties Review Course. 2005Jackson CW. Treatment of Depressive Disorder: Home Study and Literature Analysis. College of Psychiatricand Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2005Jackson CW. Treatment of Personality and Eating Disorders. Home Study and Literature Analysis. College ofPsychiatric and Neurologic Pharmacists. Board of Pharmaceutical Specialties Review Course. 2005Jackson CW. Treatment of Schizophrenia and Movement Disorders. Home Study and Literature Analysis.College of Psychiatric and Neurologic Pharmacists Review Course. 2005Jackson CW, Curtis JL. Sleep Disorders. In: Dipiro JT, Talbert RT, Yee GV, Matzke GR, Wells BG, Posey LM.Pharmacotherapy. A Pathophysiologic Approach. Sixth Edition. McGraw Hill Company. 2005; 1321-1332.Jackson CW, Curtis JL. Sleep Disorders. In: Schwinghammer TL, Pharmacotherapy Casebook: A PatientFocused Approach. Sixth Edition. McGraw Hill Company. 2005; 76:222-27.Jackson CW. Personality and Eating Disorders. College of Psychiatric and Neurologic Pharmacist. Board ofPharmaceutical Specialties Review Course. 2004Jackson CW. Depression. College of Psychiatric and Neurologic Pharmacists. Board of PharmaceuticalSpecialties Review Course. 2004Jackson CW. Treatment of Schizophrenia and Movement Disorders. College of Psychiatric and NeurologicReview Course. Board of Pharmaceutical Specialties Review Course. 2004Jackson CW. Treatment of Schizophrenia and Movement Disorders. American Society of Health SystemPharmacists. Board of Pharmaceutical Specialties Review Course. 2003.Jackson CW. Treatment of Depressive Disorders. American Society of Health System Pharmacists. Board ofPharmaceutical Specialties. 2003Jackson CW. Treatment of Personality and Eating Disorders. American Society of Pharmacists. Board ofPharmaceutical Specialties. 2003Jackson CW. Mood Disorders. In: Benz JD. (Ed.) Pharmacotherapy Self-Assessment Program (PSAP), FourhtEdition. American College of Clinical Pharmacy. 2002; 5:203-259.Abstracts in Refereed Journals (*denotes student/resident)Cates ME, Jackson CW, Feldman JM, Clifton JA. Add on amantadine therapy to induce weight loss inpsychiatric patients already receiving topiramate therapy. Journal of Pharmacy Practice. 2009; 22:203-204.Ford FR*, Jackson CW. Pilot study: focus on the ability of nursing staff to recognize drug-drug interactions.International Pharmaceutical Abstracts. 2000; 36:2305.13
Curriculum vitaeCherry Wyant JacksonAlgozzine TW, Pitner JK, Mintzer JE, Jackson CW. Evaluation of the effectiveness of lorazepam for thetreatment of agitation in the demented elderly. Pharmacotherapy, 1996: 16:499.Peer Reviewed National Poster Presentations (*denotes student or resident)Ledbetter K*, Jackson CW. The prevalence and treatment of anxiety and/or depression among pharmacystudents. ASHP Midyear Meeting, Orlando, FL, December 2017.Dang JT, Slater N, Meyer A, Jackson C, Whitley HP, Andrus M. Survey of Students’ Perception of SOAP NoteWriting in Advanced Pharmacy Practice Experiences (APPEs). Poster session presented at: Midyear ClinicalMeeting; American Society of Health-System Pharmacists; 2016 Dec; Las Vegas, NV, USA.Slater N, Andrus MR, Meyer A, Jackson CW. Whitley H. Survey of student’s perception of SOAP note writingin advanced pharmacy experiences. Abstract. American College of Clinical Pharmacy Annual Meeting,Hollywood, Florida, October 23-26, 2016.Andrus MR, Carroll DG, Lisenby KM, Stevenson K, Fan S, Gaillard P, Jackson CW. Survey of ambulatory carepreceptors regarding SOAP note writing in advanced pharmacy practice experiences (APPEs). AmericanAssociation of Colleges of Pharmacy Annual Meeting, Anaheim, California, 2016.Linna LE*, Jackson CW. Incidence of neutropenia in clozapine patients in an outpatient clinic in Alabama.American Society of Health-System Pharmacists. Midyear Clinical Meeting, New Orleans, Louisiana,December 2015.Jackson CW, Cohen JL, Riese DJ. Best practices for promoting high level scholarship in pharmacy practicedepartments. (Invited) American Association of Colleges of Pharmacy. July 24, 2015, National Harbor,Maryland, USA.Ransom S*, Jackson CW. Aripiprazole for the resolution of antipsychotic induced hyperprolactinemia: a caseseries. American Society of Health System Pharmacist Midyear Clinical Meeting, Anaheim, California,December 2014.Kleppinger E, Hutchinson A, Jackson C, Eiland L, Thornhill L*, Hornsby L. Incorporation of active- learning in acontinuing professional education program focused on OTC product recommendations. AmericanAssociation of Colleges of Pharmacy Summer Meeting, Grapevine, Texas, July 2014.Cates ME, Jackson CW, Feldman JM, Clifton JA*. Add on amantadine therapy to induce weight loss inpsychiatric patients already receving topiramate therapy.
Preceptor of Excellence, Auburn University 2009-2010 . Roche Preceptor of the Year, Class of 2001 2000-2001 . Professor of the Year, Entry Level PharmD, Class of 2001 2000-2001 . Psychopharmacology (Nurse Practitioner Residents) 2008-present . University of Georgia. Advanced Practice Experience-Acute Care 2005-2007 .
